US Stock MarketDetailed Quotes
LGND Ligand Pharmaceuticals
- 124.330
- +3.710+3.08%
Close Nov 26 16:00 ET
- 122.580
- -1.750-1.41%
Pre 05:59 ET
2.35BMarket Cap49.93P/E (TTM)
124.440High119.779Low182.79KVolume120.620Open120.620Pre Close22.40MTurnover0.99%Turnover Ratio42.29P/E (Static)18.90MShares129.90052wk High2.79P/B2.30BFloat Cap58.97052wk Low--Dividend TTM18.52MShs Float173.736Historical High--Div YieldTTM3.86%Amplitude4.115Historical Low122.522Avg Price1Lot Size
Ligand Pharmaceuticals Key Stats
EPS
According to the latest financial report of Ligand Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.39. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Ligand Pharmaceuticals's free cash flow? The latest report shows it as 22.29M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Ligand Pharmaceuticals shows that the company's current ratio is 12.49, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Ligand Pharmaceuticals, the quick ratio is 10.57, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Ligand Pharmaceuticals? The latest ROE figure is -0.89%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Ligand Pharmaceuticals, the total asset return on investment (ROA) is -0.79%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Ligand Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 95.27%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Ligand Pharmaceuticals, the net profit margin is -13.84%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data